reply
by an investor
7mos ago
from New York University
in New York, NY, USA
Ali
Yes it all depends on what "healthcare" roll-up you are doing and where you are doing it in. Besides what everyone else already mentioned about the specific complexities within a specific area of healthhcare, there are the regulatory concerns in the US that are state specific.
reply
by a searcher
5mos ago
from University of Edinburgh
in UK
Hi Ali, it really depends on the niche you’re focusing on and, crucially, the entry point for the roll-up — for example, acquiring a single established platform versus building hub-and-spoke from smaller regional operators. I’d also be very mindful of dis-synergy risk: situations where the combined group underperforms the sum of the individual businesses due to integration friction, management distraction, cultural mismatch, or incremental central overhead. In healthcare especially, those factors can erode margins faster than expected if not tightly managed from day one.